Loading…
Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus
Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are i...
Saved in:
Published in: | ACS chemical biology 2011-01, Vol.6 (1), p.106-116 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43 |
---|---|
cites | cdi_FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43 |
container_end_page | 116 |
container_issue | 1 |
container_start_page | 106 |
container_title | ACS chemical biology |
container_volume | 6 |
creator | Campbell, Jennifer Singh, Atul K Santa Maria, John P Kim, Younghoon Brown, Stephanie Swoboda, Jonathan G Mylonakis, Eleftherios Wilkinson, Brian J Walker, Suzanne |
description | Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are inhibited by β-lactams. Although mecA expression is essential for β-lactam resistance, it is not sufficient. Here we show that blocking the expression of wall teichoic acids (WTAs) by inhibiting the first enzyme in the pathway, TarO, sensitizes methicillin-resistant S. aureus (MRSA) strains to β-lactams even though the β-lactam-resistant transpeptidase, PBP2A, is still expressed. The dramatic synergy between TarO inhibitors and β-lactams is noteworthy not simply because strategies to overcome MRSA are desperately needed but because neither TarO nor the activities of the native TPs are essential in MRSA strains. The “synthetic lethality” of inhibiting TarO and the native TPs suggests a functional connection between ongoing WTA expression and peptidoglycan assembly in S. aureus. Indeed, transmission electron microscopy shows that S. aureus cells blocked in WTA synthesis have extensive defects in septation and cell separation, indicating dysregulated cell wall assembly and degradation. Our studies imply that WTAs play a fundamental role in S. aureus cell division and raise the possibility that synthetic lethal compound combinations may have therapeutic utility for overcoming antibiotic-resistant bacterial infections. |
doi_str_mv | 10.1021/cb100269f |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3025082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>846898978</sourcerecordid><originalsourceid>FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43</originalsourceid><addsrcrecordid>eNptkV1rFDEUhgdR7Ide-AckNyK9WE0yH5vcCHVptbCg2IqX4SQ500mZSaaTTMv-FP-t2W67KHiVA-fhOTnnLYo3jH5glLOPRjNKeSPbZ8Uhq-tqIWS5fL6vuTwojmK8obQqGyFfFgecyoYxRg-L35cbnzpMzpA1pg56sgrDGGZvt4V2HpILPpIfeIe5CeQ8t2BAnx5Q79FsAaIx3SN68gv6nlyhM13IylPjLIHs-o5jcjZc9xsDnnx2IT6MjRiJ8-Qywdht-mCCMXMkME84x1fFixb6iK8f3-Pi5_nZ1errYv3ty8XqdL2AaknTogXNK4taNxoZYMsbXTWtFlzkDTVYLjhYViJlEkFKUXOrGaLVaHhdtlV5XHzaecdZD2hNXm2CXo2TG2DaqABO_dvxrlPX4U6VlNdU8Cx4_yiYwu2MManBRYN9Dx7DHJWo8tGFXIpMnuxIM4UYJ2z3UxhV2yTVPsnMvv37W3vyKboMvNsBYKK6CfPk85X-I_oD1cKrEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>846898978</pqid></control><display><type>article</type><title>Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Campbell, Jennifer ; Singh, Atul K ; Santa Maria, John P ; Kim, Younghoon ; Brown, Stephanie ; Swoboda, Jonathan G ; Mylonakis, Eleftherios ; Wilkinson, Brian J ; Walker, Suzanne</creator><creatorcontrib>Campbell, Jennifer ; Singh, Atul K ; Santa Maria, John P ; Kim, Younghoon ; Brown, Stephanie ; Swoboda, Jonathan G ; Mylonakis, Eleftherios ; Wilkinson, Brian J ; Walker, Suzanne</creatorcontrib><description>Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are inhibited by β-lactams. Although mecA expression is essential for β-lactam resistance, it is not sufficient. Here we show that blocking the expression of wall teichoic acids (WTAs) by inhibiting the first enzyme in the pathway, TarO, sensitizes methicillin-resistant S. aureus (MRSA) strains to β-lactams even though the β-lactam-resistant transpeptidase, PBP2A, is still expressed. The dramatic synergy between TarO inhibitors and β-lactams is noteworthy not simply because strategies to overcome MRSA are desperately needed but because neither TarO nor the activities of the native TPs are essential in MRSA strains. The “synthetic lethality” of inhibiting TarO and the native TPs suggests a functional connection between ongoing WTA expression and peptidoglycan assembly in S. aureus. Indeed, transmission electron microscopy shows that S. aureus cells blocked in WTA synthesis have extensive defects in septation and cell separation, indicating dysregulated cell wall assembly and degradation. Our studies imply that WTAs play a fundamental role in S. aureus cell division and raise the possibility that synthetic lethal compound combinations may have therapeutic utility for overcoming antibiotic-resistant bacterial infections.</description><identifier>ISSN: 1554-8929</identifier><identifier>EISSN: 1554-8937</identifier><identifier>DOI: 10.1021/cb100269f</identifier><identifier>PMID: 20961110</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Anti-Bacterial Agents - metabolism ; Anti-Bacterial Agents - pharmacology ; beta-Lactams - antagonists & inhibitors ; Cell Wall - chemistry ; Cell Wall - metabolism ; Colocasia - enzymology ; Methicillin Resistance ; Methicillin-Resistant Staphylococcus aureus - metabolism ; Penicillin-Binding Proteins - metabolism ; Peptidoglycan - biosynthesis ; Peptidyl Transferases - metabolism ; Teichoic Acids - antagonists & inhibitors ; Teichoic Acids - biosynthesis ; Tunicamycin - antagonists & inhibitors</subject><ispartof>ACS chemical biology, 2011-01, Vol.6 (1), p.106-116</ispartof><rights>Copyright © 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43</citedby><cites>FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20961110$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campbell, Jennifer</creatorcontrib><creatorcontrib>Singh, Atul K</creatorcontrib><creatorcontrib>Santa Maria, John P</creatorcontrib><creatorcontrib>Kim, Younghoon</creatorcontrib><creatorcontrib>Brown, Stephanie</creatorcontrib><creatorcontrib>Swoboda, Jonathan G</creatorcontrib><creatorcontrib>Mylonakis, Eleftherios</creatorcontrib><creatorcontrib>Wilkinson, Brian J</creatorcontrib><creatorcontrib>Walker, Suzanne</creatorcontrib><title>Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus</title><title>ACS chemical biology</title><addtitle>ACS Chem. Biol</addtitle><description>Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are inhibited by β-lactams. Although mecA expression is essential for β-lactam resistance, it is not sufficient. Here we show that blocking the expression of wall teichoic acids (WTAs) by inhibiting the first enzyme in the pathway, TarO, sensitizes methicillin-resistant S. aureus (MRSA) strains to β-lactams even though the β-lactam-resistant transpeptidase, PBP2A, is still expressed. The dramatic synergy between TarO inhibitors and β-lactams is noteworthy not simply because strategies to overcome MRSA are desperately needed but because neither TarO nor the activities of the native TPs are essential in MRSA strains. The “synthetic lethality” of inhibiting TarO and the native TPs suggests a functional connection between ongoing WTA expression and peptidoglycan assembly in S. aureus. Indeed, transmission electron microscopy shows that S. aureus cells blocked in WTA synthesis have extensive defects in septation and cell separation, indicating dysregulated cell wall assembly and degradation. Our studies imply that WTAs play a fundamental role in S. aureus cell division and raise the possibility that synthetic lethal compound combinations may have therapeutic utility for overcoming antibiotic-resistant bacterial infections.</description><subject>Anti-Bacterial Agents - metabolism</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>beta-Lactams - antagonists & inhibitors</subject><subject>Cell Wall - chemistry</subject><subject>Cell Wall - metabolism</subject><subject>Colocasia - enzymology</subject><subject>Methicillin Resistance</subject><subject>Methicillin-Resistant Staphylococcus aureus - metabolism</subject><subject>Penicillin-Binding Proteins - metabolism</subject><subject>Peptidoglycan - biosynthesis</subject><subject>Peptidyl Transferases - metabolism</subject><subject>Teichoic Acids - antagonists & inhibitors</subject><subject>Teichoic Acids - biosynthesis</subject><subject>Tunicamycin - antagonists & inhibitors</subject><issn>1554-8929</issn><issn>1554-8937</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptkV1rFDEUhgdR7Ide-AckNyK9WE0yH5vcCHVptbCg2IqX4SQ500mZSaaTTMv-FP-t2W67KHiVA-fhOTnnLYo3jH5glLOPRjNKeSPbZ8Uhq-tqIWS5fL6vuTwojmK8obQqGyFfFgecyoYxRg-L35cbnzpMzpA1pg56sgrDGGZvt4V2HpILPpIfeIe5CeQ8t2BAnx5Q79FsAaIx3SN68gv6nlyhM13IylPjLIHs-o5jcjZc9xsDnnx2IT6MjRiJ8-Qywdht-mCCMXMkME84x1fFixb6iK8f3-Pi5_nZ1errYv3ty8XqdL2AaknTogXNK4taNxoZYMsbXTWtFlzkDTVYLjhYViJlEkFKUXOrGaLVaHhdtlV5XHzaecdZD2hNXm2CXo2TG2DaqABO_dvxrlPX4U6VlNdU8Cx4_yiYwu2MManBRYN9Dx7DHJWo8tGFXIpMnuxIM4UYJ2z3UxhV2yTVPsnMvv37W3vyKboMvNsBYKK6CfPk85X-I_oD1cKrEQ</recordid><startdate>20110121</startdate><enddate>20110121</enddate><creator>Campbell, Jennifer</creator><creator>Singh, Atul K</creator><creator>Santa Maria, John P</creator><creator>Kim, Younghoon</creator><creator>Brown, Stephanie</creator><creator>Swoboda, Jonathan G</creator><creator>Mylonakis, Eleftherios</creator><creator>Wilkinson, Brian J</creator><creator>Walker, Suzanne</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110121</creationdate><title>Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus</title><author>Campbell, Jennifer ; Singh, Atul K ; Santa Maria, John P ; Kim, Younghoon ; Brown, Stephanie ; Swoboda, Jonathan G ; Mylonakis, Eleftherios ; Wilkinson, Brian J ; Walker, Suzanne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anti-Bacterial Agents - metabolism</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>beta-Lactams - antagonists & inhibitors</topic><topic>Cell Wall - chemistry</topic><topic>Cell Wall - metabolism</topic><topic>Colocasia - enzymology</topic><topic>Methicillin Resistance</topic><topic>Methicillin-Resistant Staphylococcus aureus - metabolism</topic><topic>Penicillin-Binding Proteins - metabolism</topic><topic>Peptidoglycan - biosynthesis</topic><topic>Peptidyl Transferases - metabolism</topic><topic>Teichoic Acids - antagonists & inhibitors</topic><topic>Teichoic Acids - biosynthesis</topic><topic>Tunicamycin - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campbell, Jennifer</creatorcontrib><creatorcontrib>Singh, Atul K</creatorcontrib><creatorcontrib>Santa Maria, John P</creatorcontrib><creatorcontrib>Kim, Younghoon</creatorcontrib><creatorcontrib>Brown, Stephanie</creatorcontrib><creatorcontrib>Swoboda, Jonathan G</creatorcontrib><creatorcontrib>Mylonakis, Eleftherios</creatorcontrib><creatorcontrib>Wilkinson, Brian J</creatorcontrib><creatorcontrib>Walker, Suzanne</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campbell, Jennifer</au><au>Singh, Atul K</au><au>Santa Maria, John P</au><au>Kim, Younghoon</au><au>Brown, Stephanie</au><au>Swoboda, Jonathan G</au><au>Mylonakis, Eleftherios</au><au>Wilkinson, Brian J</au><au>Walker, Suzanne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus</atitle><jtitle>ACS chemical biology</jtitle><addtitle>ACS Chem. Biol</addtitle><date>2011-01-21</date><risdate>2011</risdate><volume>6</volume><issue>1</issue><spage>106</spage><epage>116</epage><pages>106-116</pages><issn>1554-8929</issn><eissn>1554-8937</eissn><abstract>Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase (TP) with reduced susceptibility to β-lactam antibiotics. PBP2A cross-links nascent peptidoglycan when the native TPs are inhibited by β-lactams. Although mecA expression is essential for β-lactam resistance, it is not sufficient. Here we show that blocking the expression of wall teichoic acids (WTAs) by inhibiting the first enzyme in the pathway, TarO, sensitizes methicillin-resistant S. aureus (MRSA) strains to β-lactams even though the β-lactam-resistant transpeptidase, PBP2A, is still expressed. The dramatic synergy between TarO inhibitors and β-lactams is noteworthy not simply because strategies to overcome MRSA are desperately needed but because neither TarO nor the activities of the native TPs are essential in MRSA strains. The “synthetic lethality” of inhibiting TarO and the native TPs suggests a functional connection between ongoing WTA expression and peptidoglycan assembly in S. aureus. Indeed, transmission electron microscopy shows that S. aureus cells blocked in WTA synthesis have extensive defects in septation and cell separation, indicating dysregulated cell wall assembly and degradation. Our studies imply that WTAs play a fundamental role in S. aureus cell division and raise the possibility that synthetic lethal compound combinations may have therapeutic utility for overcoming antibiotic-resistant bacterial infections.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>20961110</pmid><doi>10.1021/cb100269f</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1554-8929 |
ispartof | ACS chemical biology, 2011-01, Vol.6 (1), p.106-116 |
issn | 1554-8929 1554-8937 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3025082 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Anti-Bacterial Agents - metabolism Anti-Bacterial Agents - pharmacology beta-Lactams - antagonists & inhibitors Cell Wall - chemistry Cell Wall - metabolism Colocasia - enzymology Methicillin Resistance Methicillin-Resistant Staphylococcus aureus - metabolism Penicillin-Binding Proteins - metabolism Peptidoglycan - biosynthesis Peptidyl Transferases - metabolism Teichoic Acids - antagonists & inhibitors Teichoic Acids - biosynthesis Tunicamycin - antagonists & inhibitors |
title | Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses in Staphylococcus aureus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthetic%20Lethal%20Compound%20Combinations%20Reveal%20a%20Fundamental%20Connection%20between%20Wall%20Teichoic%20Acid%20and%20Peptidoglycan%20Biosyntheses%20in%20Staphylococcus%20aureus&rft.jtitle=ACS%20chemical%20biology&rft.au=Campbell,%20Jennifer&rft.date=2011-01-21&rft.volume=6&rft.issue=1&rft.spage=106&rft.epage=116&rft.pages=106-116&rft.issn=1554-8929&rft.eissn=1554-8937&rft_id=info:doi/10.1021/cb100269f&rft_dat=%3Cproquest_pubme%3E846898978%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a470t-fab24debb6be1aef26b46fb828611bad282ad13e019ea99852db1eedbec253f43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=846898978&rft_id=info:pmid/20961110&rfr_iscdi=true |